***This article is a story curated by SparkAmpLab that can be shared or modified for re-post***
Inherited genes make us who we are. But they also can predispose us to illness and disease. Manus Robotics and DNArails are two new health tech startups working to find solutions for those who have diseases often caused by inherited genes. Founded at MIT by acclaimed roboticist Dr. Harry Asada and his graduate students, Manus Robotics specializes in wearable technologies to improve the lives of people who are unable to properly use their hand. And DNArails, which originates in Taiwan, is a digital health and bioinformatics startup that focuses on human genomics analysis, and uses machine learning to provide new insights into disease.
More than 17 million stroke survivors worldwide are unable to perform simple tasks on a daily basis. Dr. Harry Asada and other researchers in his team at MIT have developed a wearable technology that helps a dysfunctional hand grasp objects. Victims of a stroke, neuromuscular diseases, or a traumatic injury who have lost their ability to fully use their hand can benefit greatly from Asada’s invention, and can regain their independence and quality of life. The robotic device is worn around the wrist and works with two grippers, enabling the user to hold an object like a bottle with one hand, and uncap it with the other hand.
The robotic wearable moves in sync with a user’s fingers to grab and hold onto objects of various shapes and sizes. With the wearable, a user’s own muscle movements are enhanced so that it’s possible to hold onto objects. For instance, Grip X can hold down a piece of paper so the other hand can write something down. The Grip X effectively gives you two extra fingers to grip with.
Grip X can assist stroke survivors with everyday activities like getting dressed, grooming and eating, improving their quality of life immensely.
Strokes can be caused by a number of factors, including genetic disorders. DNArails is a health tech startup that provides technologies to analyze and interpret genomic data. The company has developed a simple, reliable and accurate genomic analysis tool.
DNArails has created GENISYS, an interactive, user-friendly platform which makes the recording of genetic variants simpler, faster and more accurate. Through GENISYS, DNArails provides clinical labs with an intuitive, transparent and standardized analysis solution for genetic testing in cancer and hereditary diseases.
GENISYS makes it possible to integrate the genetic data of each member of a family. This is crucial, as by further analyzing the genetic model, the family database can predict the risk of rare diseases and illnesses caused by a single gene.
Founded in 2014 by a team of young Taiwanese Entrepreneurs with biomedical, artificial intelligence, data analysis, and information security experience, DNArails is unique in its approach as a health tech startup. It has developed its own data mining algorithm to interpret data, and applies machine learning technology to ensure data accuracy. The startup also applies machine learning to genetic analysis in order to help clinicians and researchers find genetically-linked solutions to disease. The company prides itself in its ability to quickly discover the biomedical meaning inside a gene.
Manus Robotics and DNArails are two health startups that are applying modern technology in untraditional ways to help people thrive. Because of their contributions to their field, later this month, Manus Robotics and DNArails are two of the 467 revolutionary startups chosen to show off their innovative technologies at CompuTEX Taipei.